2021
DOI: 10.1080/01612840.2021.1998261
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms and Methods to Understand Depressive Symptoms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 69 publications
0
6
0
Order By: Relevance
“… 38 Frailty increases an individual's likelihood of experiencing depressive symptoms, which has been linked to a reduction in the quantity of monoamines neurotransmitters (e.g., dopamine, noradrenaline, serotonin) in synaptic clefts and depressive pathophysiology. 39 , 40 Sustained expression of these neurochemical imbalances can enforce and prolong depressive symptoms, leading to increased frailty and poor health outcomes.…”
Section: Discussionmentioning
confidence: 99%
“… 38 Frailty increases an individual's likelihood of experiencing depressive symptoms, which has been linked to a reduction in the quantity of monoamines neurotransmitters (e.g., dopamine, noradrenaline, serotonin) in synaptic clefts and depressive pathophysiology. 39 , 40 Sustained expression of these neurochemical imbalances can enforce and prolong depressive symptoms, leading to increased frailty and poor health outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Biomarkers are also important in understanding the underlying mechanisms of symptom development. For example, TBI induces cytokine changes, and thus changes in levels of IL-6 (pro-inflammatory) and IL-10 (anti-inflammatory), among others, may be indicative of depressive symptoms and can be useful in depressive symptom research (Bodnar et al, 2018; Sheikh-Wu et al, 2022). Begum et al (2020) measured FGF21 and MCP-1 among concussed athletes and found that increased serum concentrations of FGF21 and MCP-1 correlated greater likelihood for reporting headache and fatigue.…”
Section: Discussionmentioning
confidence: 99%
“…Affective symptoms such as depression, anxiety, and stress are key features of mood or psychiatric disorders (bipolar and post-traumatic stress) (Alexopoulos, 2019; Lundberg et al, 2020a; Rohani et al, 2018; Sheikh-Wu et al, 2021). Affective symptoms are experienced across populations and, at times (stress and sadness), are normal and expected (Sheikh-Wu et al, 2021). However, unmanaged affective symptoms reduce persons' quality of life and health outcomes (Alexopoulos, 2019; Lundberg et al, 2020a; Ridout et al, 2018).…”
Section: Telomere Attrition and Symptomsmentioning
confidence: 99%
“…Specific affective (mood disorders), cognitive (function and impairment), and physical (function and activity) symptoms are seen across multiple chronic illnesses, and research indicates that the experience of symptoms, such as frequency and severity of occurrence, is influenced by environmental, psychological, and physiological factors (Miaskowski et al, 2017;Sheikh-Wu et al, 2021). Understanding the symptom experience includes an understanding of the contribution of biological and behavioral mechanisms is important as it has the potential to advance our understanding of symptoms across multiple illnesses (NINR, 2018(NINR, , 2020.…”
Section: Introductionmentioning
confidence: 99%